Search results
Apr 4, 2024 · Print. Healthcare providers who administer the Moderna COVID-19 Vaccine (2023-2024 Formula) to individuals ages 6 months through 11 years should ensure the correct volume of the vaccine (0.25 mL) is withdrawn from the vial and administered to the recipient. Discard vial and excess volume after extracting a single dose.
Jul 13, 2023 · Printable posters and graphics developed to help you communicate COVID-19 recommendations in your school. See ongoing mitigation guidance and prevention and support for administrators, teachers, staff, and parents in schools and child care programs.
May 14, 2024 · Print. What You Need to Know. CDC recommends the 2023–2024 updated COVID-19 vaccines—Pfizer-BioNTech, Moderna, or Novavax—to protect against serious illness from COVID-19. Everyone aged 5 years and older ‡ should get 1 dose of an updated COVID-19 vaccine to protect against serious illness from COVID-19.
Last Updated Oct. 4, 2023. Source: National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. Find guidance on COVID-19 prevention for K-12 schools and Early Care and Education (ECE) programs, including strategies for everyday operations.
Mar 8, 2024 · COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC. Updated Mar. 8, 2024. Español | Other Languages. Print. What You Need to Know. CDC recommends the 2023–2024 updated COVID-19 vaccines: Pfizer-BioNTech, Moderna or Novavax to protect against serious illness from COVID-19.
Mar 18, 2024 · Updated Mar. 18, 2024. Print. Summary of Recent Changes. Updates as of September 23, 2022. In most circumstances, asymptomatic HCP with higher-risk exposures do not require work restriction.
Sep 11, 2020 · Updated Sept. 11, 2020. Print. If you have a fever, cough or other symptoms, you might have COVID-19. Most people have mild illness and are able to recover at home. If you think you may have been exposed to COVID-19, contact your healthcare provider. Keep track of your symptoms.
